Quick answer: The GLP-1 research history starts with academic work in the 1980s and early 1990s. It showed that a gut hormone is cut from a larger precursor encoded in the glucagon gene. BioLean1 Sema is sold as a synthetic GLP-1 analog for laboratory research, and its background sits in that body of published science.
What is GLP-1 and where does it come from?
GLP-1 stands for glucagon-like peptide-1. It is a short chain of amino acids made by specialized cells in the lining of the intestine, called L-cells. Some neurons in the brainstem also make it.
It is not made on its own. Cells first build a larger precursor called proglucagon. Enzymes then cut that precursor into different pieces depending on the tissue. In the pancreas the main piece is glucagon. In the gut, GLP-1 is one of the pieces. The active form is called GLP-1(7-36) amide and is 30 amino acids long.
How did researchers discover GLP-1?
The path began with an observation. In the 1960s, researchers saw that glucose taken by mouth triggered a bigger insulin response than the same glucose given directly into the blood. That pointed to a signal from the gut. We cover that part in our incretin research history article.
The GLP-1 piece came later. In 1983, a group at Massachusetts General Hospital that included Graeme Bell and Joel Habener reported the cloned proglucagon gene sequence. It held glucagon plus two related sequences nobody had described. Those became known as glucagon-like peptides.
In 1987, several academic groups, including Habener's in Boston and Jens Juul Holst's in Copenhagen, reported the shortened form. In perfused pancreas studies it stimulated insulin release strongly. That linked the gene sequence to the gut signal.
Why did researchers build GLP-1 analogs?
Natural GLP-1 is hard to work with. An enzyme called DPP-4 clips the front end of the peptide, and published work from the mid-1990s showed this happens within minutes. The clipped fragment no longer activates the receptor well.
That created a practical problem for laboratory research. An analog is a modified version of a natural peptide. Researchers have explored changes that slow breakdown so the molecule stays measurable longer in a study. BioLean1 Sema is described on its product page as a synthetic GLP-1 analog. The page does not list its sequence, so we do not describe its structure here.
GLP-1 research timeline at a glance
| Period | Milestone | Type of work |
|---|---|---|
| 1960s | Oral glucose shown to drive a larger insulin response than glucose given into the blood | Physiology studies |
| 1983 | Proglucagon gene sequence reveals glucagon-like segments | Gene cloning |
| 1987 | GLP-1(7-36) amide reported to stimulate insulin release | Perfused pancreas and cell studies |
| Early 1990s | GLP-1 receptor cloned; a lizard venom peptide, exendin-4, found to act on it | Molecular biology |
| Mid-1990s | DPP-4 identified as the main route of breakdown | Biochemistry |
What has published laboratory research examined?
The GLP-1 receptor belongs to the class B family of G protein-coupled receptors. These are surface proteins that pass signals into the cell. In the pancreatic beta cell, receptor activation raises an internal messenger called cAMP. Cell studies connect this to insulin release.
Preclinical research has also examined GLP-1 signaling in brain circuits tied to satiety, and its effect on how quickly the stomach empties. Our product page describes the same themes: glucose-related systems, appetite and satiety signaling, and energy balance. This work is a mix of cell and preclinical studies. Findings about the natural hormone do not automatically carry over to any one analog.
For a different receptor profile, see BioLean3 Reta vs BioLean2 Tirz.
What is in the BioLean1 Sema vial?
BioLean1 Sema ships as a lyophilized (freeze-dried) powder in a 10mg vial. It is sold for laboratory and analytical research only. Our peptides are synthesized at a WHO/GMP and ISO 9001 certified laboratory in California.
The product page does not give a CAS number, molecular formula or molecular weight, so we do not state them here.
How is BioLean1 Sema tested?
Three checks matter for any peptide. Mass spectrometry confirms identity. HPLC measures purity. A content figure shows how much peptide is in the vial. A good report matches the product name, vial size and lot, and shows an identity result that fits the compound.
The certificate above is the place to check these items for this product. Our line-by-line certificate guide explains each field.
Frequently asked questions
Is GLP-1 the same as glucagon?
No. Both are cut from the same precursor, proglucagon, but they are different peptides. They act on different receptors.
What does GLP-1 receptor agonist mean?
An agonist is a molecule that binds a receptor and activates it. A GLP-1 receptor agonist activates the GLP-1 receptor.
What does the 7-36 in GLP-1(7-36) mean?
The numbers mark positions in the precursor-derived sequence. The active form starts at position 7 and ends at position 36, where the chain finishes with an amide group.
Does the BioLean1 Sema page list a sequence or molecular weight?
No. It lists the fill quantity, format and research category, so we only state what the page provides.
Does BioLean1 Sema come in sizes other than 10mg?
Our catalog currently lists the 10mg vial only.
Every lot we sell has a Certificate of Analysis you can read before you order. Questions before you buy? Our team is in Chandler, Arizona: (888) 745-1505 or our contact page.
View BioLean1 Sema | 10mgAll products sold by BioPure Peptides are intended strictly for in-vitro laboratory and research use only. They are not for human or animal consumption. These statements have not been evaluated by the U.S. Food and Drug Administration, and these products are not intended to diagnose, treat, cure, or prevent any disease.